Evidence map›Paper›PMID 38300707›Full record

ArticleJCI insight2024

ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia.

Vladimir Camarena, Monique M Williams, Alejo A Morales, Mohammad F Zafeer, Okan V Kilic, Ali Kamiar, Clemer Abad, Monica A Rasmussen, Laurence M Briski, LéShon Peart and 7 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Physiology (Bethesda, Md.) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Case Report: NovelFrontiers in genetics · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 4 countries.

Vladimir CamarenaDr. John T. Macdonald Foundation Department of Human Genetics.
Monique M WilliamsDepartment of Medicine, Division of Cardiology.
Alejo A MoralesDr. John T. Macdonald Foundation Department of Human Genetics.
Mohammad F ZafeerJohn P. Hussmann Institute for Human Genomics.
Okan V KilicDr. John T. Macdonald Foundation Department of Human Genetics.
Ali KamiarInterdisciplinary Stem Cell Institute.
Clemer AbadDr. John T. Macdonald Foundation Department of Human Genetics.
Monica A RasmussenDepartment of Medical Education; and.
Laurence M BriskiDepartment of Pathology and Laboratory Medicine, University of Miami Leonard M. Miller School of Medicine Miami, Florida, USA.
LéShon PeartDr. John T. Macdonald Foundation Department of Human Genetics.
Guney BademciDr. John T. Macdonald Foundation Department of Human Genetics.
Deborah S BarbouthDr. John T. Macdonald Foundation Department of Human Genetics.
Sarah SmithsonDepartment of Clinical Genetics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom.
Gaofeng WangDr. John T. Macdonald Foundation Department of Human Genetics.
Lina A ShehadehDepartment of Medicine, Division of Cardiology.
Katherina WalzDr. John T. Macdonald Foundation Department of Human Genetics.
Mustafa TekinDr. John T. Macdonald Foundation Department of Human Genetics.
University of Miami · USUniversity Hospitals Bristol NHS Foundation Trust · GB

Funding

Medical Scientist Training ProgramT32GM145462 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALESSIA FORNONI, Daniel Jon Liebl · 2022 to 2026
$3.9M
NIGMS NIH HHS T32 GM145462
6 · The paper itself

Abstract

Geleophysic dysplasia-1 (GD1) is an autosomal recessive disorder caused by ADAMTS-like 2 (ADAMTSL2) variants. It is characterized by distinctive facial features, limited joint mobility, short stature, brachydactyly, and life-threatening cardiorespiratory complications. The clinical spectrum spans from perinatal lethality to milder adult phenotypes. We developed and characterized cellular and mouse models, to replicate the genetic profile of a patient who is compound heterozygous for 2 ADAMTSL2 variants, namely p.R61H and p.A165T. The impairment of ADAMTSL2 secretion was observed in both variants, but p.A165T exhibited a more severe impact. Mice carrying different allelic combinations revealed a spectrum of phenotypic severity, from lethality in knockout homozygotes to mild growth impairment observed in adult p.R61H homozygotes. Homozygous and hemizygous p.A165T mice survived but displayed severe respiratory and cardiac dysfunction. The respiratory dysfunction mainly affected the expiration phase, and some of these animals had microscopic post-obstructive pneumonia. Echocardiograms and MRI studies revealed a significant systolic dysfunction, accompanied by a reduction of the aortic root size. Histology verified the presence of hypertrophic cardiomyopathy with myocyte hypertrophy, chondroid metaplasia, and mild interstitial fibrosis. This study revealed a substantial correlation between the degree of impaired ADAMTSL2 secretion and the severity of the observed phenotype in GD1.

Indexed as

ADAMTS ProteinsBone Diseases, DevelopmentalLimb Deformities, CongenitalAdultAnimalsHumansMiceMutationPhenotypeADAMTSL2 protein, humanADAMTS ProteinsExtracellular matrixGenetic diseasesGeneticsMolecular genetics

Identifiers

PMID38300707
PMCPMC10972594
OpenAlexW4391451362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.